Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Perrigo Trims Workforce, Ships Tysabri License, Stays European Course

Executive Summary

The firm is reducing its non-production workforce by 750, a decision made after three representatives of disgruntled investor Starboard Value joined its board. Perrigo charts a course of recovery for its struggling international consumer health business, but some analysts are convinced it took a wrong turn with its 2015 investment in European OTC drug and nutritional product businesses and brands.

Advertisement

Related Content

Perrigo Makes Its Rx Generics Business Look Right At Home
Perrigo CEO Takes Faith In Rx Generics Business To Exit Door With Him
Perrigo OTC Growth Rides Innovation Path Wider Than Switches
Perrigo Consumer Results' Significance Grows With Tysabri In Past
Perrigo 'Unlocks Value' But Weak 2017 Outlook Impedes Revelry
Starboard Agreement Tilts Perrigo Toward Rx Generics Sale
Perrigo Starts Branded Consumer Product Rescue Mission In Belgium
Culture Shock In Europe For Perrigo With Branded Consumer Business
Perrigo Navigates Earnings Storm Weathering Change At Helm
Perrigo OTC Brand Journey Detours Into Management, Operating Problems

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

PS120125

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel